NovoCure Ltd Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NovoCure Ltd quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2014 to Q3 2024.
  • NovoCure Ltd Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$30.6M, a 38.2% increase year-over-year.
  • NovoCure Ltd Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$150M, a 24.1% increase year-over-year.
  • NovoCure Ltd annual Net Income (Loss) Attributable to Parent for 2023 was -$207M, a 124% decline from 2022.
  • NovoCure Ltd annual Net Income (Loss) Attributable to Parent for 2022 was -$92.5M, a 58.6% decline from 2021.
  • NovoCure Ltd annual Net Income (Loss) Attributable to Parent for 2021 was -$58.4M, a 395% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$150M -$30.6M +$18.9M +38.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 -$169M -$33.4M +$24M +41.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-30
Q1 2024 -$193M -$38.8M +$14.3M +27% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-30
Q4 2023 -$207M -$47.1M -$9.78M -26.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-30
Q3 2023 -$197M -$49.5M -$22.9M -86.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 -$174M -$57.4M -$33.4M -139% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-30
Q1 2023 -$141M -$53.1M -$48.4M -1042% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-30
Q4 2022 -$92.5M -$37.3M -$10.8M -41% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 -$81.7M -$26.6M -$13.5M -102% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$68.2M -$24M -$9.37M -64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-26
Q1 2022 -$58.9M -$4.65M -$519K -12.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-26
Q4 2021 -$58.4M -$26.5M -$31.4M -638% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$27M -$13.1M -$22.4M -241% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 -$4.57M -$14.6M -$16.3M -985% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $11.7M -$4.13M -$8.08M -204% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $19.8M $4.92M +$657K +15.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $19.2M $9.28M +$7.35M +381% Jul 1, 2020 Sep 30, 2020 10-K 2023-02-23
Q2 2020 $11.8M $1.66M +$2.93M Apr 1, 2020 Jun 30, 2020 10-K 2023-02-23
Q1 2020 $8.87M $3.95M +$16.1M Jan 1, 2020 Mar 31, 2020 10-K 2023-02-23
Q4 2019 -$7.23M $4.26M +$19.9M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$27.1M $1.93M +$13.6M Jul 1, 2019 Sep 30, 2019 10-K 2022-02-24
Q2 2019 -$40.7M -$1.27M +$14.2M +91.8% Apr 1, 2019 Jun 30, 2019 10-K 2022-02-24
Q1 2019 -$55M -$12.2M +$8.57M +41.4% Jan 1, 2019 Mar 31, 2019 10-K 2022-02-24
Q4 2018 -$63.6M -$15.6M -$4.69M -42.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$58.9M -$11.7M -$196K -1.71% Jul 1, 2018 Sep 30, 2018 10-K 2021-02-25
Q2 2018 -$58.7M -$15.5M +$5.66M +26.8% Apr 1, 2018 Jun 30, 2018 10-K 2021-02-25
Q1 2018 -$64.3M -$20.7M -$2.68M -14.8% Jan 1, 2018 Mar 31, 2018 10-K 2021-02-25
Q4 2017 -$61.7M -$10.9M +$11.2M +50.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$72.9M -$11.5M +$22.1M +65.8% Jul 1, 2017 Sep 30, 2017 10-K 2020-02-27
Q2 2017 -$95M -$21.2M +$19.4M +47.9% Apr 1, 2017 Jun 30, 2017 10-K 2020-02-27
Q1 2017 -$114M -$18M +$17.4M +49.1% Jan 1, 2017 Mar 31, 2017 10-K 2020-02-27
Q4 2016 -$132M -$22.2M +$10.8M +32.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$143M -$33.6M -$7.61M -29.2% Jul 1, 2016 Sep 30, 2016 10-K 2019-02-28
Q2 2016 -$135M -$40.6M -$11.3M -38.3% Apr 1, 2016 Jun 30, 2016 10-K 2019-02-28
Q1 2016 -$124M -$35.4M -$12.2M -52.3% Jan 1, 2016 Mar 31, 2016 10-K 2019-02-28
Q4 2015 -$112M -$32.9M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 -$26M -$7.7M -42% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 -$29.4M Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 -$23.3M Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q3 2014 -$18.3M Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.